Veritable L.P. boosted its stake in shares of Cryoport, Inc. (NASDAQ:CYRX – Get Rating) by 8.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,444 shares of the consumer goods maker's stock after buying an additional 560 shares during the quarter. Veritable L.P.'s holdings in Cryoport were worth $260,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Roubaix Capital LLC lifted its holdings in Cryoport by 123.4% during the 1st quarter. Roubaix Capital LLC now owns 164,301 shares of the consumer goods maker's stock valued at $5,736,000 after buying an additional 90,745 shares in the last quarter. GW&K Investment Management LLC lifted its holdings in Cryoport by 3.7% during the 1st quarter. GW&K Investment Management LLC now owns 799,732 shares of the consumer goods maker's stock valued at $27,919,000 after buying an additional 28,415 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in Cryoport by 21.7% during the 4th quarter. Envestnet Asset Management Inc. now owns 70,648 shares of the consumer goods maker's stock valued at $4,180,000 after buying an additional 12,596 shares in the last quarter. Bridgewater Associates LP raised its holdings in shares of Cryoport by 15.3% in the 4th quarter. Bridgewater Associates LP now owns 49,706 shares of the consumer goods maker's stock valued at $2,941,000 after purchasing an additional 6,591 shares in the last quarter. Finally, Pinebridge Investments L.P. bought a new stake in shares of Cryoport in the 4th quarter valued at about $77,000. Institutional investors own 90.33% of the company's stock.

Cryoport Stock Performance

CYRX opened at $33.02 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 14.21 and a quick ratio of 13.69. The firm has a fifty day moving average price of $36.02 and a 200 day moving average price of $31.38. Cryoport, Inc. has a 1 year low of $19.82 and a 1 year high of $86.30. The stock has a market cap of $1.60 billion, a P/E ratio of -5.34 and a beta of 1.13.

Wall Street Analyst Weigh In

CYRX has been the subject of several recent research reports. BTIG Research reduced their price target on shares of Cryoport from $95.00 to $60.00 in a report on Friday, May 6th. Roth Capital dropped their target price on shares of Cryoport from $90.00 to $67.00 in a research report on Tuesday, May 3rd. KeyCorp dropped their target price on shares of Cryoport from $92.00 to $52.00 in a research report on Friday, May 6th. Needham & Company LLC boosted their target price on shares of Cryoport from $41.00 to $42.00 and gave the stock a "buy" rating in a research report on Tuesday, July 12th. Finally, B. Riley dropped their price objective on shares of Cryoport from $61.00 to $55.00 in a report on Tuesday, May 17th. Six investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of "Buy" and an average target price of $61.33.

Insider Activity at Cryoport

In related news, Director Robert J. Hariri sold 2,000 shares of the business's stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $43.29, for a total value of $86,580.00. Following the completion of the transaction, the director now directly owns 7,911 shares in the company, valued at approximately $342,467.19. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Cryoport news, Director Richard J. Berman sold 2,708 shares of the company's stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $43.05, for a total transaction of $116,579.40. Following the completion of the transaction, the director now directly owns 107,203 shares in the company, valued at $4,615,089.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert J. Hariri sold 2,000 shares of the company's stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $43.29, for a total transaction of $86,580.00. Following the transaction, the director now owns 7,911 shares of the company's stock, valued at $342,467.19. The disclosure for this sale can be found here. Company insiders own 9.70% of the company's stock.

Cryoport Profile

(Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

Featured Articles

• Get a free copy of the StockNews.com research report on Cryoport (CYRX)
• How the Pandemic Forced F5 to Flex its Software Side
• Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
• The Retail Sector: Winners And Losers From Q2 Earnings
• Can Targa Continue Rallying To Meet Its Price Target?
• Is Unity Software Ready To Rally After Rejecting AppLovin Offer?

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.